1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Op De Beeck, A. Montserret, R. Duvet, S. Cocquerel, L. Cacan, R. Barberot, B. Le Maire, M. Penin, F. Dubuisson, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 275 31428 31437 10.1074/jbc.M003003200 10807921 The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. 2000 10.2210/pdb1emz/pdb pdb_00001emz 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2237.581 ENVELOPE GLYCOPROTEIN E1 TRANSMEMBRANE DOMAIN (RESIDUES 350-370) 1 syn polymer no no GAHWGVLAGIAYFSMVGNWAK GAHWGVLAGIAYFSMVGNWAK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2000-04-05 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession RCSB Y RCSB 2000-03-20 REL REL This peptide was chemically synthesized. The sequence of this peptide is naturally found in hepatitis C virus. sample sodium 2,2 dimethyl-2-silapentane-5-sulfonate (DSS) in the internal nmr reference back calculated data agree with experimental NOESY spectrum,structures with the least restraint violations,structures with the lowest energy 50 1 DQF-COSY TOCSY 2D NOESY 5.7 ambient 293 K the structure is based on 337 Noe derived distance constraints distance geometry, simulated annealing, molecular dynamic, energy minimization 1 closest to the average 4 mM E1(350-370), 50% H2O, 50% D2 trifluoroethanol (v/v) 50% H2O, 50% D2 trifluoroethanol (v/v) Varian Inc. collection VNMR 6.1 Brunger A.T. structure solution X-PLOR 3.1 Brunger A.T. refinement X-PLOR 3.1 500 Varian UNITYPLUS GLY 1 n 1 GLY 1 A ALA 2 n 2 ALA 2 A HIS 3 n 3 HIS 3 A TRP 4 n 4 TRP 4 A GLY 5 n 5 GLY 5 A VAL 6 n 6 VAL 6 A LEU 7 n 7 LEU 7 A ALA 8 n 8 ALA 8 A GLY 9 n 9 GLY 9 A ILE 10 n 10 ILE 10 A ALA 11 n 11 ALA 11 A TYR 12 n 12 TYR 12 A PHE 13 n 13 PHE 13 A SER 14 n 14 SER 14 A MET 15 n 15 MET 15 A VAL 16 n 16 VAL 16 A GLY 17 n 17 GLY 17 A ASN 18 n 18 ASN 18 A TRP 19 n 19 TRP 19 A ALA 20 n 20 ALA 20 A LYS 21 n 21 LYS 21 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 SOLUTION STRUCTURE OF FRAGMENT (350-370) OF THE TRANSMEMBRANE DOMAIN OF HEPATITIS C ENVELOPE GLYCOPROTEIN E1 1 N N A HIS 3 A HIS 3 HELX_P A LYS 21 A LYS 21 1 1 19 VIRAL PROTEIN transmembrane domain, envelope protein E1, hepatitis C virus, Viral protein Q9Q3N3_9HEPC UNP 1 350 Q9Q3N3 GAHWGVLAGIAYFSMVGNWAK 350 370 1EMZ 1 21 Q9Q3N3 A 1 1 21 1 P 1